Cargando…
OXA-48 Dominance Meets Ceftazidime-Avibactam: A Battle Against Life-Threatening Carbapenem-Resistant Klebsiella pneumoniae Infections in the Intensive Care Unit
Objective In this study, we aimed to describe the outcomes in ICU patients with bloodstream infection (BSI) or ventilatory-associated pneumonia (VAP) due to carbapenem-resistant Klebsiella pneumoniae (CRKP) who received ceftazidime-avibactam treatment at a tertiary care university hospital. Methods...
Autores principales: | Önal, Uğur, Tüzemen, Ülkü, Kaya, Pınar K, İşçimen, Remzi, Girgin, Nermin K, Özakın, Cüneyt, Kahveci, Ferda, Akalın, Halis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563373/ https://www.ncbi.nlm.nih.gov/pubmed/37822692 http://dx.doi.org/10.7759/cureus.46780 |
Ejemplares similares
-
Evaluation of the combination treatments with intravenous fosfomycin for carbapenem-resistant Klebsiella pneumoniae
por: Önal, Uğur, et al.
Publicado: (2023) -
Prognostic Risk Factors in Ventilator-Associated Pneumonia
por: Karakuzu, Ziyaettin, et al.
Publicado: (2018) -
Trends of Bloodstream Infections in a University Hospital During 12 Years
por: Ülkü Tüzemen, Nazmiye, et al.
Publicado: (2022) -
OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
por: Fröhlich, Christopher, et al.
Publicado: (2019) -
Evaluation of ceftazidime/avibactam for treatment of carbapenemase-producing carbapenem-resistant Enterobacterales with OXA-48 and/or NDM genes with or without combination therapy
por: Alqahtani, Hajar, et al.
Publicado: (2022)